As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral antidepressants.

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

PH284 nasal spray increased hunger in cancer cachexia patients, showing a 71% improvement in subjective hunger scores compared to baseline. The phase 2A study demonstrated PH284's safety, with no ...

THREE of the most dangerous medicines in the world have been revealed – and millions of Brits already use them. A cold and ...

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid symptom relief.

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to ... the medication to monitor for side effects. To qualify for treatment ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as ... t improving their symptoms and are causing undesirable side effects, such as weight gain and sexual issues.

The new FDA approval means people can use the nasal spray as-is to treat depression ... plus potential side effects to be aware of. Thea Gallagher, PsyD, is a clinical associate professor at ...